199 related articles for article (PubMed ID: 37189343)
1. Triphenyltin(IV) Carboxylates with Exceptionally High Cytotoxicity against Different Breast Cancer Cell Lines.
Predarska I; Saoud M; Morgan I; Lönnecke P; Kaluđerović GN; Hey-Hawkins E
Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189343
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Evaluation of Antiproliferative Properties of Novel Organotin(IV) Carboxylate Compounds with Propanoic Acid Derivatives on a Panel of Human Cancer Cell Lines.
Pantelić NĐ; Božić B; Zmejkovski BB; Banjac NR; Dojčinović B; Wessjohann LA; Kaluđerović GN
Molecules; 2021 May; 26(11):. PubMed ID: 34071809
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, photophysical properties and structures of organotin-Schiff bases utilizing aromatic amino acid from the chiral pool and evaluation of the biological perspective of a triphenyltin compound.
Basu Baul TS; Kehie P; Duthie A; Guchhait N; Raviprakash N; Mokhamatam RB; Manna SK; Armata N; Scopelliti M; Wang R; Englert U
J Inorg Biochem; 2017 Mar; 168():76-89. PubMed ID: 28024187
[TBL] [Abstract][Full Text] [Related]
4. Triphenyltin(IV) benzoates with diazenyl/imino scaffold exhibiting remarkable apoptosis mediated by reactive oxygen species.
Basu Baul TS; Dutta D; Duthie A; Prasad R; Rana NK; Koch B; Tiekink ERT
J Inorg Biochem; 2017 Aug; 173():79-92. PubMed ID: 28505480
[TBL] [Abstract][Full Text] [Related]
5. The triphenyltin(VI) complexes of NSAIDs and derivatives. Synthesis, crystal structure and antiproliferative activity. Potent anticancer agents.
Dokorou V; Primikiri A; Kovala-Demertzi D
J Inorg Biochem; 2011 Feb; 105(2):195-201. PubMed ID: 21194618
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line.
Predarska I; Saoud M; Morgan I; Eichhorn T; Kaluđerović GN; Hey-Hawkins E
Dalton Trans; 2022 Jan; 51(3):857-869. PubMed ID: 34877948
[TBL] [Abstract][Full Text] [Related]
7. Advancement towards tin-based anticancer chemotherapeutics: structural modification and computer modeling approach to drug-enzyme interactions.
Basu Baul TS; Dutta D; de Vos D; Höpfl H; Pooja ; Singh P
Curr Top Med Chem; 2012; 12(24):2810-26. PubMed ID: 23368104
[TBL] [Abstract][Full Text] [Related]
8. Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
Sirajuddin M; McKee V; Tariq M; Ali S
Eur J Med Chem; 2018 Jan; 143():1903-1918. PubMed ID: 29133050
[TBL] [Abstract][Full Text] [Related]
9. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
10. Synergetic anticancer activity of gold porphyrin appended to phenyl tin malonate organometallic complexes.
Nguyen C; Toubia I; Diring S; Hadj-Kaddour K; Gary-Bobo M; Kobeissi M; Odobel F
Dalton Trans; 2021 Apr; 50(13):4583-4592. PubMed ID: 33705511
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structural characterization and in vitro inhibitory studies against human breast cancer of the bis-(2,6-di-tert-butylphenol)tin(IV) dichloride and its complexes.
Shpakovsky DB; Banti CN; Beaulieu-Houle G; Kourkoumelis N; Manoli M; Manos MJ; Tasiopoulos AJ; Hadjikakou SK; Milaeva ER; Charalabopoulos K; Bakas T; Butler IS; Hadjiliadis N
Dalton Trans; 2012 Dec; 41(48):14568-82. PubMed ID: 23052471
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and in vitro biological evaluation of novel organotin(IV) compounds with derivatives of 2-(5-arylidene-2,4-dioxothiazolidin-3-yl)propanoic acid.
Pantelić NĐ; Zmejkovski BB; Božić B; Dojčinović B; Banjac NR; Wessjohann LA; Kaluđerović GN
J Inorg Biochem; 2020 Oct; 211():111207. PubMed ID: 32801055
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological investigations and Petra/Osiris/Molinspiration (POM) analyses of newly synthesized potentially bioactive organotin(IV) carboxylates.
Tariq M; Sirajuddin M; Ali S; Khalid N; Tahir MN; Khan H; Ansari TM
J Photochem Photobiol B; 2016 May; 158():174-83. PubMed ID: 26974578
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structural characterization and biological studies of the triphenyltin(IV) complex with 2-thiobarbituric acid.
Balas VI; Verginadis II; Geromichalos GD; Kourkoumelis N; Male L; Hursthouse MB; Repana KH; Yiannaki E; Charalabopoulos K; Bakas T; Hadjikakou SK
Eur J Med Chem; 2011 Jul; 46(7):2835-44. PubMed ID: 21521629
[TBL] [Abstract][Full Text] [Related]
15. Mode of action of tin-based anti-proliferative agents: Biological studies of organotin(IV) derivatives of fatty acids.
Nath M; Vats M; Roy P
J Photochem Photobiol B; 2015 Jul; 148():88-100. PubMed ID: 25900554
[TBL] [Abstract][Full Text] [Related]
16. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
17. Effect of chain length on the cytotoxic activity of (alkyl-ω-ol)triphenyltin(IV) loaded into SBA-15 nanostructured silica and in vivo study of SBA-15~Cl|Ph
Bensing C; Mojić M; Bulatović M; Edeler D; Pérez-Quintanilla D; Gómez-Ruiz S; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
Biomater Adv; 2022 Sep; 140():213054. PubMed ID: 35964389
[TBL] [Abstract][Full Text] [Related]
18. Amino acetate functionalized Schiff base organotin(IV) complexes as anticancer drugs: synthesis, structural characterization, and in vitro cytotoxicity studies.
Baul TS; Basu S; de Vos D; Linden A
Invest New Drugs; 2009 Oct; 27(5):419-31. PubMed ID: 18941713
[TBL] [Abstract][Full Text] [Related]
19. Genotoxic Effects of Tributyltin and Triphenyltin Isothiocyanates, Cognate RXR Ligands: Comparison in Human Breast Carcinoma MCF 7 and MDA-MB-231 Cells.
Hunakova L; Horvathova E; Majerova K; Bobal P; Otevrel J; Brtko J
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857277
[TBL] [Abstract][Full Text] [Related]
20. Design, Cytotoxicity and Antiproliferative Activity of 4-Amino-5-methyl-thieno[2,3-d]pyrimidine-6-carboxylates against MFC-7 and MDA-MB-231 Breast Cancer Cell Lines.
Mavrova A; Dimov S; Sulikovska I; Yancheva D; Iliev I; Tsoneva I; Staneva G; Nikolova B
Molecules; 2022 May; 27(10):. PubMed ID: 35630793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
